Vantage Biosciences Ltd
Research and experimental development on biotechnology · London
ActiveUnited KingdomIncorporated 2023Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
£8,343,012
Cash
—
Turnover
—
Profit / loss
—
Current assets
£1,009,909
Creditors < 1 year
£16,488
Equity
£8,343,012
Average employees
Not available
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2025-12-31Company | 2024-12-31Company | 2023-12-31Company |
|---|---|---|---|
| Balance sheet | |||
| Net assets | £8,343,012 | £4,726,869 | £1,560,337 |
| Equity | £8,343,012 | £4,726,869 | £1,560,337 |
| Assets | |||
| Fixed assets | £7,329,066 | £360,327 | £359,629 |
| Current assets | £1,009,909 | £6,453,719 | £1,316,679 |
| Liabilities | |||
| Creditors within one year | £16,488 | £2,113,903 | £93,114 |
| Net current assets | £1,048,608 | £4,385,133 | £1,225,708 |
| Assets less current liabilities | £8,377,674 | £4,745,460 | £1,585,337 |
| Source evidence | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesShow 1 satisfied / released
Fixed · created 2025-03-12 · satisfied 2026-03-09
—
Satisfied